Yuzhou Zhu

No ORCID on file · 1 paper in corpus
review 2026
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics16111582

With colorectal cancer (CRC) accounting for over 1.9 million new cases and 930,000 deaths globally in 2020, there is a critical need for innovative indicators to forecast disease advancement and therapeutic outcomes. The gut microbiome has …